Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
16.57
Oct 22 • 3:59 PM ET Dollar change-0.16 Percentage change(-0.96%)
Aftermarket Close
16.45
Aftermarket • 4:00 PM ET Dollar change-0.12 Percentage change(-0.72%)
Index
-
Market Cap
284.07M
Enterprise Value
175.27M
Income
-67.61M
Sales
142.56M
Book/sh
5.56
Cash/sh
6.38
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
98
IPO
Jul 16, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
1.99
P/B
2.98
P/C
2.60
P/FCF
-
EV/EBITDA
-
EV/Sales
1.23
Quick Ratio
3.66
Current Ratio
4.04
Debt/Eq
0.01
LT Debt/Eq
0.00
Option/Short
Yes / Yes
EPS (ttm)
-4.17
EPS next Y
-1.78
EPS next Q
-0.85
EPS this Y
5.69%
EPS next Y
50.28%
EPS next 5Y
68.19%
EPS past 3/5Y
58.51% 34.71%
Sales past 3/5Y
91.46% -23.93%
EPS Y/Y TTM
-5.43%
Sales Y/Y TTM
182.05%
EPS Q/Q
49.36%
Sales Q/Q
210.67%
Insider Own
22.55%
Insider Trans
1.25%
Inst Own
7.06%
Inst Trans
-16.78%
ROA
-39.86%
ROE
-57.62%
ROIC
-72.58%
Gross Margin
63.22%
Oper. Margin
-35.48%
Profit Margin
-47.43%
SMA20
-20.00%
SMA50
-25.29%
SMA200
-15.14%
Trades
Shs Outstand
15.15M
Shs Float
13.28M
52W High
27.24 -39.17%
52W Low
11.36 45.80%
Volatility
9.86% 7.26%
ATR (14)
1.55
RSI (14)
28.30
Beta
0.35
Rel Volume
1.39
Avg Volume
208.77K
Volume
290,227
Perf Week
-18.21%
Perf Month
-27.04%
Perf Quarter
-11.58%
Perf Half Y
-5.31%
Perf YTD
5.21%
Perf Year
1.59%
Perf 3Y
157.50%
Perf 5Y
-85.55%
Perf 10Y
-
Prev Close
16.73
Price
16.57
Change %
-0.96%
Date Action Analyst Rating Change Price Target Change
Sep-17-26Initiated Craig Hallum Buy $40
Aug-27-26Initiated B. Riley Securities Buy $37
Jun-16-26Initiated The Benchmark Company Buy $30
Mar-16-26Initiated Lake Street Buy $29
Feb-11-26Initiated Roth Capital Buy $36
Jan-18-23Initiated Cantor Fitzgerald Overweight $7
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leogrande Hudson BlakeDirectorOct 04 '26Option Exercise0.002,00008,001Oct 06 06:01 AM
Lo Hoi ChunChief Financial OfficerSep 30 '26Option Exercise0.007,6350573,648Oct 02 08:36 AM
Leogrande Hudson BlakeDirectorSep 04 '26Option Exercise0.002,00006,001Sep 04 08:44 AM
Rosin Brian JCFO of IM8 (US) LLCAug 24 '26Buy21.1918,000381,42018,000Aug 26 08:23 AM
Rosin Brian JCFO of IM8 (US) LLCAug 25 '26Buy22.805,100116,28023,100Aug 26 08:23 AM
Lo Hoi ChunChief Financial OfficerAug 21 '26Option Exercise0.0078,5513566,013Aug 24 09:43 PM
Yeung Danny Sheng WuChief Executive OfficerAug 20 '26Option Exercise0.0053,9535137,647Aug 24 09:41 PM
Yeung Danny Sheng WuChief Executive OfficerAug 24 '26Buy21.2317,181364,673112,416Aug 24 09:41 PM
Yeung Danny Sheng WuChief Executive OfficerAug 20 '26Buy18.317,500137,32595,235Aug 24 09:41 PM
Leogrande Hudson BlakeDirectorAug 04 '26Option Exercise0.002,00104,001Aug 05 10:45 AM
Leogrande Hudson BlakeDirectorJul 04 '26Option Exercise0.002,00002,000Jul 07 07:35 AM
Cheng Yin PanDirectorJun 15 '26Option Exercise0.0015,873059,051Jun 16 09:10 AM
VANDERVEEN DAVIDDirectorJun 15 '26Option Exercise0.006,944045,249Jun 16 08:38 AM
Prenetics Global Ltd. is a health sciences company, which engages in providing consumer health products and services. The firm offers scientifically formulated supplements under the IM8 brand, sports nutrition products under the Europa platform, and direct-to-consumer DNA tests through the CircleDNA brand. It is also involved in establishing a Bitcoin treasury for the exploration of applications within the healthcare ecosystem. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and has dual headquartered in Charlotte, the United States and Hong Kong.
Co-FounderMr. Sheng Wu Yeung
Chief of Staff & VP of People & OperationsMs. Samantha Kwok
General CounselMr. Brian Chae
Chief Clinical OfficerDr. Senthil Kumar Sundaram M.D.
Chief Financial Officer of U.S.Mr. Brian J. Rosin